Biological development and manufacturing concept available from Lonza

Lonza Pharma & Biotech has launched a new concept in biological manufacturing and development, Ibex Solutions.

This concept couples flexibility through an in facility build-out with fully tailored business models and the company’s expertise and service network in Visp. Ibex biomanufacturing comprises a modular, technology-independent development and manufacturing complex capable of supporting activities across multiple technologies — mammalian, microbial, cellular or bio-conjugate — and from late discovery to manufacture.

“Lonza has been creating innovative manufacturing and production solutions for 120 years, and we are continuing to pioneer clinical and commercial manufacturing in multiple technologies all over the world,” said Lonza’s Pharma & Biotech COO, Marc Funk. “We have been working with our partners to understand what we can offer that will really change the game for them, and that’s why we have created Ibex.”

Construction began in June with a formal groundbreaking ceremony expected in the second half of 2017. It is anticipated that several hundred new positions will be created.